IRCT2016011621087N1已完成未知
Erythropoietin effect on ischemic_reperfusion injury in cronary artery bypass graft surgery
Pooyesh Darou company and Shahid Beheshti University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •The inclusion criterion are revascularization requirement according to angiographic evidence,cronary artery bypass graft (CABG) surgery in elective situation, for the first time and with cardiopulmonary bypass(CPB). The exclusion criteria are comprised of history of myocardial infarction in the past 3 months, previous myocardial trauma or major surgery in the past 3 months, Cr>2, receiving streptokinase or previous reperfusion treatments, EPO intake in the recent 6 months, known thrombo-embolic disorder, malignant disease,uncontrolled hypertension and polycythemia
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Erythropoeitin to facilitate stroke recoveryCirculatory SystemStroke, not specified as haemorrhage or infarctionStrokeISRCTN50896492King's College Hospital NHS Foundation Trust (UK)90
已完成
3 期
Evaluation of Erythropoietin's effect in patients consciousnessTraumatic Brain Injury.Other specified intracranial injury with loss of consciousness of unspecified durationS06.899IRCT20190429043416N1Tehran University of Medical Sciences18
进行中（未招募）
不适用
Erythropoietin for the repair of cerebral injury in very preterm infants, a randomized, double-blind, placebo-controlled, prospective, and multicenter clinical studyEUCTR2014-000612-34-ATniversitätsSpital Zürich120
尚未招募
Unknown
Erythropoietin for neuroprotection in preterm infants: A longitudinal randomized trialCTRI/2024/06/068517Mahatma gandhi medical college
已完成
不适用
The effect of erythropoietin in reduction of tissue–reperfusion injury after coronary artery baypass graftTissue-reperfusiuon injury.Atherosclerotic heart diseaseIRCT138809102799N1Deputy of Research and Technology of Mazandarn University of Medical Sciences50